The Chemours Co (The Chemours Co) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Chemours Co is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of The Chemours Co's Risk Assessment

For the Specialty Chemicals subindustry, The Chemours Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Chemours Co's Risk Assessment Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, The Chemours Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Chemours Co's Risk Assessment falls into.

The Chemours Co (NYSE:CC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

The Chemours Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of The Chemours Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

The Chemours Co (The Chemours Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

CC:Mexico 2CU:Germany 2CU:Germany

Address

1007 Market Street, Wilmington, DE, USA, 19801

Website

https://www.chemours.com

The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.

Executives

Ron Christopher Charles	officer: Senior Vice President, People	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers	director	1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane	director	300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko	officer: President, Thermal & Specializ	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman	officer: Senior Vice President and CFO	1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough	officer: SVP Corp Communications & CBO	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott	officer: SVP, Chief Enterprise Transfor	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy	director	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar	officer: Pres Advanced Performance Mat	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza	officer: President, Thermal Spec Solns	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel	officer: VP, CAO & Controller	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan	officer: SVP, CFO	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock	officer: SVP, Chief Development Officer	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher	officer: SVP, People and Health Service	ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801